Login
$GH
$147.54 +$3.51 (2.44%) After hours

Company Executives

Officer Age In this role Joined 2023 pay Source
Helmy Eltoukhy Also a director
Chairperson and Co-Chief Executive Officer
47 Not stated Not stated $11,591
AmirAli Talasaz Also a director
Co-Chief Executive Officer
46 Not stated Not stated $26,415
Michael Bell
Chief Financial Officer
57 Since 2021
5 years
Not stated $4,123,993
Darya Chudova
Chief Technology Officer
52 Since 2023
3 years
2015 $4,755,541
Craig Eagle
Chief Medical Officer
59 Since 2021
5 years
Not stated $3,485,356
Christopher Freeman
Chief Commercial Officer
52 Since 2021
5 years
Not stated $3,523,052
Kumud Kalia
Chief Information Officer
60 Since 2020
6 years
Not stated Not reported
Terilyn Juarez Monroe
Chief People Officer
59 Since 2024
2 years
Not stated Not reported
John Saia
Chief Legal Officer and Corporate Secretary
53 Since 2022
4 years
Not stated Not reported
Robert A. Parks
Chief Accounting Officer
Title from the Form 4 dated Nov 9, 2026
Not stated Not stated Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 28, 2026 · updated by the 8-K of Nov 3, 2026

Directors
12
serving now
Independent
9 of 11
stated in the proxy; 1 not stated
Average tenure
5.0 years
from year joined
CEO also chairs the board
Yes
Helmy Eltoukhy
Director On board Independent Committees Other public boards Pay Source
Helmy Eltoukhy
2013
13 years
Not independent None stated None stated Paid as CEO
AmirAli Talasaz
Not stated Not independent None stated None stated Paid as CEO
Ian Clark
2017
9 years
Independent
Governance Committee · Chair
Takeda Pharmaceutical Company Limited $470,242
Manuel Hidalgo Medina
2024
2 years
Independent
Nominating and Corporate Governance Committee
Bristol-Myers Squibb Company $425,286
Alex M. Azar II
2025
1 year
Independent
Nominating and Corporate Governance Committee
None stated $725,332
Steve Krognes
2022
4 years
Independent
Audit Committee · Chair
Denali Therapeutics Inc., argenx SE, Pliant Therapeutics, Inc. $425,286
Vijaya Gadde
2020
6 years
Independent
Compensation Committee · Chair
Planet Labs PBC $425,286
Roberto Mignone
2024
2 years
Independent
Audit Committee
Teva Pharmaceuticals $425,286
Myrtle Potter
2021
5 years
Independent
Audit Committee
Opentrons Labworks, Inc. $425,286
Musa Tariq
2023
3 years
Independent None stated None stated $425,286
Kevin R. Sayer Joined Nov 2, 2026
- - - - -
Meghan Joyce Leaving at the meeting
Not stated Independent
Audit Committee
None stated $425,286

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.

No related-party transactions disclosed

The proxy filed Apr 28, 2026 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support